Latent iron deficiency in utero is associated with abnormal auditory neural myelination in ≥ 35 weeks gestational age

Sanjiv B Amin1, Mark Orlando, Hongyue Wang

  • 1Division of Neonatology, Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, NY.

Insights

Infants with latent iron deficiency at birth show delayed auditory neural myelination. This study links low cord serum ferritin levels to prolonged auditory brainstem evoked response interpeak latencies in newborns.

Area of Science:

  • Neuroscience
  • Neonatal Health
  • Iron Metabolism

Background:

  • Auditory neural myelination is crucial for infant neurodevelopment.
  • Iron deficiency in utero may impact fetal development.
  • Auditory brainstem evoked response (ABR) interpeak latencies serve as an index of auditory neural myelination.

Purpose of the Study:

  • To investigate the association between cord serum ferritin levels and auditory brainstem evoked response interpeak latencies.
  • To assess auditory neural myelination in infants with latent iron deficiency compared to those with normal iron status.

Main Methods:

  • Prospective study comparing infants with latent iron deficiency (cord serum ferritin 11-75 ng/mL) and normal iron status (>75 ng/mL).
  • Inclusion criteria: infants ≥ 35 weeks gestational age with risk factors for poor in utero iron status.
  • Auditory brainstem evoked response measured within 48 hours of birth to evaluate interpeak latencies (I-III, III-V, I-V).

Main Results:

  • 12 out of 45 infants studied had latent iron deficiency.
  • Infants with latent iron deficiency exhibited significantly prolonged interpeak latencies (P = .01) compared to controls.
  • Findings remained significant after controlling for potential confounders.

Conclusions:

  • In utero latent iron deficiency is associated with abnormal auditory neural myelination at birth.
  • This association is observed in infants born at or after 35 weeks gestational age.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Neurulation01:30

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the anterior...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...